Treace Medical Concepts, Inc. (TMCI) Institutional Ownership & Insider Trading

117 institutions reported holding Treace Medical Concepts, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 12 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TMCITreace Medical Concepts, Inc.Follow TMCI — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 277.7M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 10 Nov, in 17 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

117 institutions held 49.0% of the shares. Across filers that reported both quarters, shares held changed -11.4%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	117	32	-11.4%	37	29	30	26
Mar 26	117	36	+3.3%	34	24	27	23
Dec 25	112	36	-13.7%	27	24	33	32
Sep 25	116	40	+5.2%	34	10	28	20
Jun 25	123	38	+1.4%	44	16	40	25
Mar 25	137	38	+2.4%	40	25	42	20
Dec 24	133	37	-8.6%	39	18	42	21
Sep 24	131	39	-5.8%	33	27	44	19

Treace Medical Concepts, Inc. — questions

Who owns Treace Medical Concepts, Inc. stock?: 117 institutions reported Treace Medical Concepts, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: ARMISTICE CAPITAL, LLC (9.8%), BANK OF AMERICA CORP /DE/ (5.1%), GAGNON SECURITIES LLC (4.7%).
Are Treace Medical Concepts, Inc. insiders buying or selling?: 12 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Treace Medical Concepts, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.